152 related articles for article (PubMed ID: 26542524)
1. Clinical features and treatment of patients with esophageal cancer and a history of gastrectomy: a multicenter, questionnaire survey in Kyushu, Japan.
Okumura H; Mori N; Tanaka T; Morita M; Toh Y; Saeki H; Maehara Y; Nakamura K; Honda H; Yoshida N; Baba H; Natsugoe S
Dis Esophagus; 2016 Nov; 29(8):1135-1143. PubMed ID: 26542524
[TBL] [Abstract][Full Text] [Related]
2. Clinical outcome of esophageal cancer patients with history of gastrectomy.
Wada H; Doki Y; Nishioka K; Ishikawa O; Kabuto T; Yano M; Monden M; Imaoka S
J Surg Oncol; 2005 Feb; 89(2):67-74. PubMed ID: 15660375
[TBL] [Abstract][Full Text] [Related]
3. Surgical treatment and prognosis of esophageal cancer after distal gastrectomy.
Wu L; Xu Z; Zhao X; Li J; Sun Y
J Gastrointest Surg; 2010 Jan; 14(1):32-7. PubMed ID: 19756882
[TBL] [Abstract][Full Text] [Related]
4. Comparison Between Esophagectomy and Definitive Chemoradiotherapy in Patients With Esophageal Cancer.
Wang BY; Hung WH; Wu SC; Chen HC; Huang CL; Lin CH; Chen HS
Ann Thorac Surg; 2019 Apr; 107(4):1060-1067. PubMed ID: 30571951
[TBL] [Abstract][Full Text] [Related]
5. Trimodality therapy of esophagectomy plus neoadjuvant chemoradiotherapy improves the survival of clinical stage II/III esophageal squamous cell carcinoma patients.
Fujiwara Y; Yoshikawa R; Kamikonya N; Nakayama T; Kitani K; Tsujie M; Yukawa M; Inoue M; Yamamura T
Oncol Rep; 2012 Aug; 28(2):446-52. PubMed ID: 22664791
[TBL] [Abstract][Full Text] [Related]
6. Systematic review and meta-analysis on the significance of salvage esophagectomy for persistent or recurrent esophageal squamous cell carcinoma after definitive chemoradiotherapy.
Kumagai K; Mariosa D; Tsai JA; Nilsson M; Ye W; Lundell L; Rouvelas I
Dis Esophagus; 2016 Oct; 29(7):734-739. PubMed ID: 26316181
[TBL] [Abstract][Full Text] [Related]
7. A phase-II/III randomized controlled trial of adjuvant radiotherapy or concurrent chemoradiotherapy after surgery versus surgery alone in patients with stage-IIB/III esophageal squamous cell carcinoma.
Ni W; Yu S; Zhang W; Xiao Z; Zhou Z; Chen D; Feng Q; Liang J; Lv J; Gao S; Mao Y; Xue Q; Sun K; Liu X; Fang D; Li J; Wang D
BMC Cancer; 2020 Feb; 20(1):130. PubMed ID: 32070309
[TBL] [Abstract][Full Text] [Related]
8. Salvage Esophagectomy After Definitive Chemoradiotherapy for Patients with Esophageal Squamous Cell Carcinoma: Who Really Benefits from this High-Risk Surgery?
Watanabe M; Mine S; Nishida K; Yamada K; Shigaki H; Matsumoto A; Sano T
Ann Surg Oncol; 2015 Dec; 22(13):4438-44. PubMed ID: 25862582
[TBL] [Abstract][Full Text] [Related]
9. Patterns of recurrence after surgery and efficacy of salvage therapy after recurrence in patients with thoracic esophageal squamous cell carcinoma.
Ni W; Yang J; Deng W; Xiao Z; Zhou Z; Zhang H; Chen D; Feng Q; Liang J; Lv J; Wang X; Wang X; Zhang T; Bi N; Deng L; Wang W
BMC Cancer; 2020 Feb; 20(1):144. PubMed ID: 32087687
[TBL] [Abstract][Full Text] [Related]
10. Comparison of salvage chemoradiation versus salvage surgery for recurrent esophageal squamous cell carcinoma after definitive radiochemotherapy or radiotherapy alone.
Chen Y; Lu Y; Wang Y; Yang H; Xia Y; Chen M; Song H; Li T; Li D; Wang J; Li S; Wang J
Dis Esophagus; 2014; 27(2):134-40. PubMed ID: 23088212
[TBL] [Abstract][Full Text] [Related]
11. Loss of Skeletal Muscle Mass During Neoadjuvant Chemoradiotherapy Predicts Postoperative Mortality in Esophageal Cancer Surgery.
Reisinger KW; Bosmans JW; Uittenbogaart M; Alsoumali A; Poeze M; Sosef MN; Derikx JP
Ann Surg Oncol; 2015 Dec; 22(13):4445-52. PubMed ID: 25893413
[TBL] [Abstract][Full Text] [Related]
12. Outcomes of Neoadjuvant Chemoradiation in Patients with Gastro-esophageal Junction Adenocarcinoma: a Retrospective Cohort Study in Iran.
Farhan F; Ghalehtaki R; Mahdavi-Seresht S; Meysamie A; Yamrali M; Farazmand B; Mohammadi N; Saraee E; Mir MR; Mir A; Lashkari M; Salarvand S; Esmati E; Samiei F
J Gastrointest Cancer; 2019 Dec; 50(4):907-912. PubMed ID: 30402826
[TBL] [Abstract][Full Text] [Related]
13. Conditional survival in patients with esophageal or gastroesophageal junction cancer after receiving various treatment modalities.
Deng W; Yang Z; Dong X; Yu R; Wang W
Cancer Med; 2021 Jan; 10(2):659-674. PubMed ID: 33314798
[TBL] [Abstract][Full Text] [Related]
14. Salvage Surgery After Chemoradiotherapy in the Management of Esophageal Cancer: Is It a Viable Therapeutic Option?
Markar S; Gronnier C; Duhamel A; Pasquer A; Théreaux J; du Rieu MC; Lefevre JH; Turner K; Luc G; Mariette C
J Clin Oncol; 2015 Nov; 33(33):3866-73. PubMed ID: 26195702
[TBL] [Abstract][Full Text] [Related]
15. Comparison of long-term outcomes between esophagectomy and chemoradiotherapy after endoscopic resection of submucosal esophageal squamous cell carcinoma.
Tanaka T; Ueno M; Iizuka T; Hoteya S; Haruta S; Udagawa H
Dis Esophagus; 2019 Dec; 32(12):. PubMed ID: 30980070
[TBL] [Abstract][Full Text] [Related]
16. Oncologic Outcomes According to Remnant Lymph Node Metastases in Pathologic T0 (ypT0) Esophageal Squamous Cell Carcinoma Following Prospective Neoadjuvant Therapy and Surgery.
Cho HJ; Kim YH; Kim HR; Kim DK; Park SI; Kim JH; Kim SB
Ann Surg Oncol; 2015; 22(6):1851-7. PubMed ID: 25344308
[TBL] [Abstract][Full Text] [Related]
17. Pretreatment Esophageal Wall Thickness Associated with Response to Chemoradiotherapy in Locally Advanced Esophageal Cancer.
Wongwaiyut K; Ruangsin S; Laohawiriyakamol S; Leelakiatpaiboon S; Sangthawan D; Sunpaweravong P; Sunpaweravong S
J Gastrointest Cancer; 2020 Sep; 51(3):947-951. PubMed ID: 31758468
[TBL] [Abstract][Full Text] [Related]
18. Outcome of delayed versus timely esophagectomy after chemoradiation for esophageal adenocarcinoma.
Levinsky NC; Wima K; Morris MC; Ahmad SA; Shah SA; Starnes SL; Van Haren RM;
J Thorac Cardiovasc Surg; 2020 Jun; 159(6):2555-2566. PubMed ID: 31767364
[TBL] [Abstract][Full Text] [Related]
19. Outcome of trimodality-eligible esophagogastric cancer patients who declined surgery after preoperative chemoradiation.
Taketa T; Correa AM; Suzuki A; Blum MA; Chien P; Lee JH; Welsh J; Lin SH; Maru DM; Erasmus JJ; Bhutani MS; Weston B; Rice DC; Vaporciyan AA; Hofstetter WL; Swisher SG; Ajani JA
Oncology; 2012; 83(5):300-4. PubMed ID: 22964903
[TBL] [Abstract][Full Text] [Related]
20. Radical esophagectomy for stage II and III thoracic esophageal squamous cell carcinoma followed by adjuvant radiotherapy with or without chemotherapy: Which is more beneficial?
Zou B; Tu Y; Liao D; Xu Y; Wang J; Huang M; Ren L; Zhu J; Gong Y; Liu Y; Zhou L; Zhou X; Peng F; Lu Y
Thorac Cancer; 2020 Mar; 11(3):631-639. PubMed ID: 31943824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]